Ozempic & Smoking
Research Study

Researchers at The University of North Carolina at Chapel Hill are conducting a study to examine the effects of an approved weight loss medication, Ozempic, among adults who smoke cigarettes. Join our compensated study today.

Fast Facts

Smoke Cigarettes Daily

Have Overweight or Obesity

21-65 Years Old

Compensation up to $850 Provided

Conducted in Chapel Hill, NC

Study Background

Help researchers learn if a medication commonly used for weight loss and blood sugar control affects responses to nicotine.

Learnings from this study will provide information about whether the medication might be helpful for people who smoke cigarettes. This is not a treatment study, and it is not intended for people who are actively trying to quit smoking.

Program participants will be asked to take Ozempic and attend weekly visits to UNC for 10 weeks. Some visits will involve cigarette smoking. 

Further research today and join our compensated study!

Additional Information

The purpose of this clinical research study is to examine the effects of an approved weight loss medication in adults who smoke cigarettes. This is not a treatment study.

You may qualify for this study if you meet the following criteria.

Key Criteria:

  • Age 21-65
  • Daily cigarette smoker and not currently trying to quit
  • Have overweight or obesity¬†
  • Willingness to take Ozempic (semaglutide) for 10 weeks
  • Able to attend brief medication visits weekly during working hours
  • No regular use of e-cigarettes or nicotine replacement therapy
  • No history of diabetes

Once enrolled, this 10-week study involves:

  • Receiving Ozempic (semaglutide) at weekly visits
  • Attending clinic appointments at UNC (some visits involve cigarette smoking)

Compensation is provided up to $850 for your time.

There is no cost for you to participate.